Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: A matched cohort study.

ABSTRACT:

Introduction

Hospitalizations due to severe injection-related infections (SIRIs) and patient-directed discharge (PDD) in people who inject drugs (PWID) are increasing, but research on readmission outcomes at PDD is limited. In this retrospective, matched cohort study we evaluated predictors of 30-day readmission by discharge status among PWID.

Methods

Among patients diagnosed with SIRIs at a tertiary hospital, Fisher's exact tests assessed differences in readmission rates by discharge status. Medications for opioid use disorder (MOUD) at discharge was defined as either having a buprenorphine dose dispensed within 24 h of discharge and buprenorphine being included in the discharge summary as a prescription, or a methadone dose dispensed inpatient within 24 h of discharge. Log

SUBMITTER: Robertson NM 

PROVIDER: S-EPMC11060916 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature